B. Willms

Both Subcutaneously and Intravenously Administered Glucagon-Like Peptide I Are Rapidly Degraded From the NH2-Terminus in Type II Diabetic Patients and in Healthy Subjects

Carolyn F. Deacon, Michael A. Nauck, Lone Pridal et al. · Diabetes · 1995 · 649 citations

Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients.

B. Willms, Jakob Werner, Jens J. Holst et al. · The Journal of Clinical Endocrinology & Metabolism · 1996 · 468 citations · Full text

Nutrition, Gastroenterology, Glucose Responses +20

Glucagonostatic Actions and Reduction of Fasting Hyperglycemia by Exogenous Glucagon-Like Peptide I(7–36) amide in type I diabetic patients

W. Creutzfeldt, N. Kleine, B. Willms et al. · Diabetes Care · 1996 · 334 citations

Gastric inhibitory polypeptide (GIP) and insulin in obesity: Increased response to stimulation and defective feedback control of serum levels

W. Creutzfeldt, R. Ebert, B. Willms et al. · Diabetologia · 1978 · 209 citations · Full text

Obesity, Metabolic Syndrome, Medicine +13

Relationship between Intracellular Distribution of Phospho<i>enol</i>pyruvate Carboxykinase, Regulation of Gluconeogenesis, and Energy Cost of Glucose Formation

Hans‐Dieter Söling, Jochen Kleineke, G. Janson et al. · European Journal of Biochemistry · 1973 · 111 citations

Energy Cost, Glucose Formation, Intracellular Distribution +19